These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16013692)

  • 1. The concept of anaesthetic-induced cardioprotection: mechanisms of action.
    Weber NC; Schlack W
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):429-43. PubMed ID: 16013692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of anaesthetics on the myocardium--new insights into myocardial protection.
    Weber NC; Preckel B; Schlack W
    Eur J Anaesthesiol; 2005 Sep; 22(9):647-57. PubMed ID: 16163910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaesthesia and myocardial ischaemia/reperfusion injury.
    Frässdorf J; De Hert S; Schlack W
    Br J Anaesth; 2009 Jul; 103(1):89-98. PubMed ID: 19502287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans.
    Xia Z; Li H; Irwin MG
    Br J Anaesth; 2016 Sep; 117 Suppl 2():ii44-ii62. PubMed ID: 27566808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications].
    Chiari P; Bouvet F; Piriou V
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):383-96. PubMed ID: 15826789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial protection by volatile anesthetics].
    Preckel B; Müllenheim J; Schlack W
    Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?
    Minguet G; Joris J; Lamy M
    Eur J Anaesthesiol; 2007 Sep; 24(9):733-45. PubMed ID: 17555610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
    Sheldrick A; Gray KM; Drew GM; Louttit JB
    Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volatile anaesthetics and cardioprotection: lessons from animal studies.
    Muntean DM; Ordodi V; Ferrera R; Angoulvant D
    Fundam Clin Pharmacol; 2013 Feb; 27(1):21-34. PubMed ID: 22804787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.
    Kunst G; Klein AA
    Anaesthesia; 2015 Apr; 70(4):467-82. PubMed ID: 25764404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Xenon - noble gas with organprotective properties].
    Preckel B; Weber N; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Aug; 39(8):456-62. PubMed ID: 15319839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategy and perspective of myocardial protection during ischaemia and reperfusion, and the role of volatile anaesthetics].
    Jović M; Krivokapić B; Lausević-Vuk L; Nezić D; Stevanović P
    Srp Arh Celok Lek; 2007; 135(9-10):583-8. PubMed ID: 18088047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of cardiac preconditioning with volatile anaesthetics.
    Hu ZY; Liu J
    Anaesth Intensive Care; 2009 Jul; 37(4):532-8. PubMed ID: 19681408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote ischaemic preconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2008 Aug; 79(3):377-86. PubMed ID: 18456674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nuclear factor-κB in volatile anaesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion.
    Wang C; Xie H; Liu X; Qin Q; Wu X; Liu H; Liu C
    Eur J Anaesthesiol; 2010 Aug; 27(8):747-56. PubMed ID: 20601888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
    Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
    Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.